IPOMarket.in — India IPO tracker
Ch 6/10
Back to Grey Market Premium — The Insider's Guide
6 min read1,059 words

Is GMP Reliable?

This is the most important question in this entire book. And the honest answer is: it depends on what you are asking it to predict.

GMP has genuine predictive value for some things and very limited value for others. The problem is that most investors use it for the things it is bad at predicting, while overlooking what it is actually good at.

What GMP Predicts Well: Direction

The most robust finding from analysing Indian IPO GMP data is that GMP correctly predicts the direction of the listing — gain vs loss — approximately 70–75% of the time.

This means:

  • When GMP is positive, the stock lists at a premium in roughly 3 of 4 cases
  • When GMP is negative, the stock lists at a discount in roughly 3 of 4 cases
  • One in four positive-GMP IPOs still lists at a discount or flat

A 70–75% directional accuracy is genuinely useful — better than a coin flip, better than most other pre-listing signals. But it is not the near-certainty that many investors treat high GMP as implying.

What GMP Predicts Poorly: Magnitude

Even when GMP correctly predicts direction, the actual listing premium or discount frequently differs significantly from what GMP implied.

Analysing the gap between GMP-implied listing price and actual listing price:

  • Within ±10% of GMP prediction: approximately 40–45% of cases
  • More than 10% below GMP prediction: approximately 35–40% of cases (GMP overstated)
  • More than 10% above GMP prediction: approximately 15–20% of cases (GMP understated)

The pattern is asymmetric: GMP is more often over-optimistic than under-optimistic. This makes sense — operators have an incentive to talk up GMP, and FOMO-driven retail demand tends to inflate grey market prices during hot markets.

Practical implication: When GMP implies a 30% listing gain, budget for a realistic range of 10–40%, not a confident 30%.

What GMP Does Not Predict At All: Long-Term Performance

GMP is about the listing price. Beyond listing day, GMP has zero predictive value.

This is the most important limit to understand. A strong GMP and strong listing say nothing about whether the stock will be worth more or less 6 months, 1 year, or 3 years later. The factors that drive long-term performance — business fundamentals, management execution, competitive dynamics — are completely unrelated to grey market sentiment.

Some of India's best long-term post-IPO performers had modest or no GMP. Some of India's worst long-term performers had exceptional GMP.

Zomato (2021): Strong GMP, strong listing, reasonable long-term performance. Paytm (2021): Positive GMP, catastrophic listing and long-term performance. Dmart (2017): Modest GMP expectations, strong listing, one of the best long-term performers.

When GMP Is Most Reliable

GMP accuracy is not uniform. It is highest in these conditions:

Moderate subscription (5x–30x): In moderately subscribed IPOs, GMP reflects genuine buy-side conviction rather than momentum-driven FOMO. The grey market participants have skin in the game without being overwhelmed by speculative froth.

Strong QIB participation: When QIBs are heavily subscribed and GMP is also high, both signals are pointing in the same direction. This dual confirmation significantly improves GMP reliability.

Stable market conditions: GMP is set in the grey market using current sentiment. If the broad market is stable or rising, there is a reasonable expectation that listing day sentiment will be similar. In volatile markets — where Nifty can move 2–3% between IPO close and listing — GMP set 3 days earlier is less reliable.

Fundamentally sound companies at reasonable valuations: For companies with clear growth stories, strong financials, and fair pricing, GMP tends to be more accurate because both grey market participants and genuine investors are aligned.

When GMP Is Least Reliable

Very high GMP (50%+): At extreme GMP levels, actual listing performance tends to disappoint relative to GMP prediction. There is a mean-reversion effect — extreme GMPs are more often a product of operator activity and FOMO than genuine institutional demand.

Large OFS components: GMP does not account for selling pressure from shareholders who received allotment and plan to sell on listing day. A high GMP with a large OFS means multiple large sellers will be hitting bids at listing — this supply can suppress the actual listing price below GMP prediction.

Market corrections during the IPO period: If the Nifty falls 2–3% between IPO subscription period and listing day, virtually every GMP will have overstated the actual listing performance. GMP is set in the grey market before the correction; the exchange corrects on listing day.

Operator-driven GMP: Particularly in SME IPOs and some mainboard issues with limited institutional participation, GMP can be manufactured to drive retail subscription. When QIB subscription is weak but GMP is high, this divergence is a warning sign.

The Calibrated GMP User

The investors who use GMP most effectively are those who have calibrated their confidence interval based on market conditions. Their mental model is:

High GMP + strong QIB + stable market + reasonable valuation: "Likely listing premium, probably 15–35% range. High confidence in positive outcome."

High GMP + weak QIB + bull market froth: "Positive listing likely but magnitude significantly uncertain. Could be 5% or 40% — I should not plan my strategy around a specific number."

Falling GMP during subscription: "Something is changing. Check for negative news, market deterioration, or institutional scepticism. Consider withdrawing application."

Negative GMP + any market condition: "Expect listing loss. Exit early if fundamentals do not justify holding for a recovery."